Clinical Trial Update: Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated bevacizumab alone or in combination with capecitabine and oxaliplatin as support therapy for metastatic colorectal cancer; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED